UN to tackle 'overly expensive' insulin prices for diabets | Eurasia Diary - ednews.net

13 December, Friday

UN to tackle 'overly expensive' insulin prices for diabets

Health A- A A+
The World Health Organization (WHO) has announced a scheme to lower the "overly expensive" price of insulin, Eurasia Diary reports citing BBC.
The UN agency wants other drug companies to produce generic versions of insulin, which it will then test. Since its discovery in 1923, the price of insulin has risen in America from $1 (78p) per vial to about $300 (£233).
About 20 million people have type 1 diabetes and need regular insulin injections to live, according to the WHO. The 54 million people worldwide with type 2 diabetes only use insulin in severe cases. A generic version of a drug is chemically similar, but produced by a different pharmaceutical company than those producing the existing drug.
The process of getting pharmaceutical companies to produce generic versions of an existing drug, and then testing it for quality and safety, is known as a prequalification programme. Once the generic version passes the safety tests, it is introduced into the global marketplace at a cheaper rate, driving down the price of the drug. The WHO has successfully run similar schemes in the past, most notably for HIV medication in 2001.
The UN agency announced the two-year initiative on Wednesday, at a conference in the Swiss city of Geneva.
Emer Cooke, a director at the WHO, said: "The simple fact is that the prevalence of diabetes is growing, the amount of insulin available to treat diabetes is too low, the prices are too high, so we need to do something."


Report a mistake by marking it and pressing Ctrl+Enter

EurasiaDiary © Must be hyperlinked when used.

Follow us:
Twitter: @Eurasia_Eng
Facebook: EurasiaEng